🎯HIT identification in muscle drug discovery: how many of your « hits » actually hold up?

MyoScreen™ changes that equation.

Multiplexed, phenotypic-quality readouts — morphology, function, spatial organisation — from a single well, at genuine screening scale. You get richer hit profiles at the primary stage, so you triage smarter and advance chemical matter that actually holds up.

Built for HTS workflows, not against them: 

✓ 384-well format — runs on your existing protocols

✓ Standardised micropatterned muscle models with tight assay windows

✓ Disease-relevant myoblasts (primary or immortalised) — assay-ready, not months of development

✓ AI-powered automated analysis — processes thousands of wells, no expert bottleneck

✓ Toxicity and cytostatic assessment built in — orthogonal data without extra experiments

💡 One well. Multiple answers. Better hit rates.

You no longer have to sacrifice biological relevance for throughput. Let’s talk about what that means for your next campaign !